bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · IEX Real-Time Price · USD
2.590
+0.140 (5.71%)
Jul 22, 2024, 10:08 AM EDT - Market open
bioAffinity Technologies Employees
bioAffinity Technologies had 14 employees as of December 31, 2022. The number of employees increased by 3 or 27.27% compared to the previous year.
Employees
14
Change (1Y)
3
Growth (1Y)
27.27%
Revenue / Employee
$352,712
Profits / Employee
-$597,574
Market Cap
30.13M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 14 | 3 | 27.27% |
Dec 31, 2021 | 11 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Bolt Biotherapeutics | 100 |
Enlivex Therapeutics | 71 |
SAB Biotherapeutics | 57 |
Surrozen | 42 |
Palatin Technologies | 34 |
Brainstorm Cell Therapeutics | 29 |
Daré Bioscience | 26 |
Akari Therapeutics, | 12 |
BIAF News
- 10 days ago - Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 13 days ago - bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung - Business Wire
- 17 days ago - BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 5 weeks ago - bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests - Business Wire
- 2 months ago - bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes - Business Wire
- 2 months ago - bioAffinity Technologies News Update - Business Wire
- 3 months ago - bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth - Business Wire
- 3 months ago - bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening - Business Wire